Please log in to view this page
Username
Password
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
